DiaMedica Therapeutics In... (DMAC)
undefined
undefined%
At close: undefined
5.38
-0.92%
After-hours Dec 13, 2024, 04:00 PM EST

DiaMedica Therapeutics Inc. Forcast

Stock Price Forecast

The 3 analysts with 12-month price forecasts for DMAC stock have an median target of 7, with a low estimate of 6 and a high estimate of 8. The median target predicts an increase of 28.91% from the current stock price of 5.43.

Analyst Consensus: Buy
Target Low Average Median High
Price $6 $7 $7 $8
Change 10.50% 28.91% 28.91% 47.33%

AI Analyst Report

HC Wainwright & Co. maintains a Buy rating on DiaM... Unlock content with Pro Subscription

Updated Nov 15, 2024

Rating Mar 24Apr 24Aug 24Oct 24Nov 24
Strong Buy 00000
Buy 21121
Hold 00000
Sell 00000
Strong Sell 00000
Total 2 1 1 2 1

Financial Forecast this Year

Revenue This Year
n/a
Revenue Next Year
0
from 0
Increased by -%
EPS This Year
-0.6
from -0.6
Increased by 0.0%
EPS Next Year
-0.76
from -0.6
Increased by -26.7%